Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cigarette Smoking by Patients With Serious Mental Illness, 1999–2016: An Increasing Disparity
Faith Dickerson, Jennifer R. Schroeder, Emily Katsafanas, et al.
Psychiatric Services (2017) Vol. 69, Iss. 2, pp. 147-153
Open Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

Increased risk of COVID‐19 infection and mortality in people with mental disorders: analysis from electronic health records in the United States
QuanQiu Wang, Rong Xu, Nora D. Volkow
World Psychiatry (2020) Vol. 20, Iss. 1, pp. 124-130
Open Access | Times Cited: 570
Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death
Felicia Ceban, Danica Nogo, Isabelle P. Carvalho, et al.
JAMA Psychiatry (2021) Vol. 78, Iss. 10, pp. 1079-1079
Open Access | Times Cited: 181
Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement
M. Patricia Rivera, Hormuzd A. Katki, Nichole T. Tanner, et al.
American Journal of Respiratory and Critical Care Medicine (2020) Vol. 202, Iss. 7, pp. e95-e112
Open Access | Times Cited: 177
Mental Health Policy in the Era of COVID-19
Matthew L. Goldman, Benjamin G. Druss, Marcela Horvitz‐Lennon, et al.
Psychiatric Services (2020) Vol. 71, Iss. 11, pp. 1158-1162
Closed Access | Times Cited: 94
Neuropsychiatric Safety and Efficacy of Varenicline, Bupropion, and Nicotine Patch in Smokers With Psychotic, Anxiety, and Mood Disorders in the EAGLES Trial
A. Eden Evins, Neal L. Benowitz, Robert West, et al.
Journal of Clinical Psychopharmacology (2019) Vol. 39, Iss. 2, pp. 108-116
Open Access | Times Cited: 89
Nicotinic acetylcholine receptors in neurological and psychiatric diseases
Alvin V. Terry, Keri Jones, Daniel Bertrand
Pharmacological Research (2023) Vol. 191, pp. 106764-106764
Open Access | Times Cited: 36
Unhealthy behaviors associated with mental health disorders: a systematic comparative review of diet quality, sedentary behavior, and cannabis and tobacco use
Petter Grahl Johnstad
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 9
Smoking in schizophrenia
Marina Šagud, Alma Mihaljević Peleš, Nela Pivac
Current Opinion in Psychiatry (2019) Vol. 32, Iss. 5, pp. 402-408
Open Access | Times Cited: 75
Cigarette Smoking and Quitting-Related Factors Among US Adult Health Center Patients with Serious Mental Illness
Sara Kalkhoran, Anne N. Thorndike, Nancy A. Rigotti, et al.
Journal of General Internal Medicine (2019) Vol. 34, Iss. 6, pp. 986-991
Open Access | Times Cited: 71
Smoking and the risk for bipolar disorder: evidence from a bidirectional Mendelian randomisation study
Jentien M. Vermeulen, Robyn E. Wootton, Jorien L. Treur, et al.
The British Journal of Psychiatry (2019) Vol. 218, Iss. 2, pp. 88-94
Open Access | Times Cited: 71
Natural cause mortality in persons with serious mental illness
Faith Dickerson, Andrea Origoni, J. Schroeder, et al.
Acta Psychiatrica Scandinavica (2018) Vol. 137, Iss. 5, pp. 371-379
Closed Access | Times Cited: 48
Cancer Screening Among Adults With and Without Serious Mental Illness
Karly A. Murphy, Elizabeth M. Stone, Rachel Presskreischer, et al.
Medical Care (2021) Vol. 59, Iss. 4, pp. 327-333
Open Access | Times Cited: 33
Evaluating tobacco industry ‘transformation’: a proposed rubric and analysis
Richard Edwards, Janet Hoek, Nancy Karreman, et al.
Tobacco Control (2022) Vol. 31, Iss. 2, pp. 313-321
Open Access | Times Cited: 24
Bidirectional two-sample Mendelian randomization study of differential white blood cell counts and schizophrenia
Perry B.M. Leung, Zipeng Liu, Yuanxin Zhong, et al.
Brain Behavior and Immunity (2024) Vol. 118, pp. 22-30
Open Access | Times Cited: 5
Effects of Psychiatric Comorbidity in Immune-Mediated Inflammatory Disease: Protocol for a Prospective Study
Ruth Ann Marrie, Lesley A. Graff, John R. Walker, et al.
JMIR Research Protocols (2018) Vol. 7, Iss. 1, pp. e15-e15
Open Access | Times Cited: 45
Non-alcoholic fatty liver disease (NAFLD) and mental illness: Mechanisms linking mood, metabolism and medicines
Anwesha Gangopadhyay, Radwa Ibrahim, Karli Theberge, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 21
Tobacco smoking and nicotine dependence in first episode and established psychosis
John Lally, Gilda Spaducci, Poonam Gardner-Sood, et al.
Asian Journal of Psychiatry (2019) Vol. 43, pp. 125-131
Open Access | Times Cited: 32
COVID-19 vaccination, incidence, and mortality rates among individuals with mental disorders in South Korea: A nationwide retrospective study
Dong-Wook Lee, Ye Seul Bae, Jae-Ryun Lee, et al.
Asian Journal of Psychiatry (2023) Vol. 85, pp. 103600-103600
Open Access | Times Cited: 10
Promoting Evidence-Based Tobacco Cessation Treatment in Community Mental Health Clinics: Results of a Pilot Implementation Study: Promouvoir le traitement de sevrage tabagique fondé sur des données probantes dans les cliniques communautaires de santé mentale : résultats d’une étude pilote de mise en œuvre
Faith Dickerson, Tyler Fink, Stacy Goldsholl, et al.
The Canadian Journal of Psychiatry (2025)
Open Access
Implementation of stop smoking support by mental healthcare professionals: cross-sectional analysis of why nothing much happens
Eline Meijer
Discover Mental Health (2025) Vol. 5, Iss. 1
Open Access
Implementation of the healthy heart tool- an algorithm with potential cardiometabolic health benefits in persons with severe mental illness
Elisabeth Lund-Stenvold, Petter Andreas Ringen, Ole A. Andreassen, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Malignant comorbidity: schizophrenia and smoking
Yury P. Sivolap, Anna A. Portnova
Neurology Bulletin (2025) Vol. LVII, Iss. 1, pp. 80-88
Closed Access
The long-term effects of a 24-week outdoor exercise program in persons with schizophrenia: Results of a 12-week follow-up period
Paulo Lourenço, Tânia Bastos, Andréia Pizarro, et al.
Schizophrenia Research (2025) Vol. 278, pp. 47-56
Closed Access
Dysregulation of miRNAs in Schizophrenia in an Egyptian Patient Population
Noha Adly, Dalia Khalifa, Shaimaa Abdel-Ghany, et al.
Research Square (Research Square) (2025)
Closed Access
Predictors of Metabolic Syndrome (MetS) and the benefits of using the MetS diagnosis for people with serious and persistent medical illness
Krista R. Noam, Christopher Bory, Elizabeth H. Flanagan, et al.
Journal of Psychiatric Research (2025) Vol. 187, pp. 108-115
Closed Access
Page 1 - Next Page

Scroll to top